Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer.
| Website: | www.diagnocure.com |
| Email: | communications@diagnocure.com |
| Main Phone: | +1 418 527-6100 |
| Address: | 4535 Wilfrid-Hamel Boulevard |
| Address 2: | Suite 250 |
| State: | QC |
| City / Town: | Quebec |
| Country: | CAN |
| Postal Code: | G1P 2J7 |
| Exchange: | TSX |
| CEO: | Yves Fradet |
| Employees: | 3 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume 0 | 52 Wk Hi 0.11 | 52 Wk Low 0.01 |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 43,040,471.00 | EPS (TTM) N/A | PE Ratio N/A | Exchange TSX |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 1.8 | 1.8 | 1.8 | 1.8 |
| Low Target Price Estimate | 1.8 | 1.8 | 1.8 | 1.8 |
| Mean Target Price Estimate | 1.8 | 1.8 | 1.8 | 1.8 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 01/14/13 | 01/14/13 | 01/14/13 | 01/14/13 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
